| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.80B | +25.8% |
| Cost of Revenue | $649.1M | +18.5% |
| R&D Expense | $1.25B | +43.5% |
| SG&A Expense | $390.1M | +31.2% |
| Operating Income | -$1.26B | -36.3% |
| Interest Expense | $40.7M | +2.0% |
| Pre-tax Income | -$1.16B | -24.5% |
| Income Tax | $454K | -87.2% |
| Net Income | -$1.15B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $678.5M | -77.2% |
| Short-term Investments | $1.51B | — |
| Accounts Receivable | $505.8M | +33.3% |
| Current Assets | $3.28B | -14.7% |
| Total Assets | $6.17B | +14.7% |
| Current Liabilities | $3.05B | +23.0% |
| Long-term Debt | $1.25B | -3.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $458.2M | +24.1% |
| Capital Expenditures | $320.7M | -24.8% |
| Investing Cash Flow | -$2.83B | -540.5% |
| Financing Cash Flow | $67.2M | +53.9% |
| Free Cash Flow | $137.5M | +341.8% |
| -24.6% |
| EPS (Basic) | -$1.87 | -20.6% |
| EPS (Diluted) | -$1.87 | -20.6% |
| Total Liabilities |
| $6.10B |
| +20.3% |
| Stockholders' Equity | $76.3M | -75.1% |